Trials / Unknown
UnknownNCT05695118
Body Composition and Fatty Liver Disease
Analysis of the Prognostic Correlation Between Body Composition Analysis and Fatty Liver Progression in Patients With Fatty Liver Using Low-dose CT
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates relationship between fatty liver prognosis and body composition analysis result based on non-contrast low dose CT in patients with fatty liver disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Non-contrast low-dose abdomen CT | target effective dose: \< 1.5 mSv It is performed twice in 6-month interval. |
| DIAGNOSTIC_TEST | Fibroscan | Fibroscan is performed within a week of low-dose CT. It is used as a reference standard of hepatic fibrosis and steatosis. |
| DIAGNOSTIC_TEST | bioelectrical impedance analysis (BIA) | BIA test is performed on the same day of low-dose CT. Commercially available model (Inbody 270) is used. |
Timeline
- Start date
- 2023-02-10
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
- First posted
- 2023-01-23
- Last updated
- 2023-08-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05695118. Inclusion in this directory is not an endorsement.